Nuzenio

Annexon Reports First

Annexon Reports First news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

State Street Corporation (ANNX) discloses 9.8M-share, 6% holding in Annexon - Stock TitanStock Titan · Fri, 07 Aug 2026 12:41:30 GMT Annexon says tanruprubart shows rapid strength gains in first 10 GBS FORWARD study patients - BitgetBitget · Thu, 06 Aug 2026 19:02:10 GMT Annexon Announces Positive Clinical Outcomes from GBS FORWARD Study on Tanruprubart - kalkinemedia.comkalkinemedia.com · Thu, 06 Aug 2026 17:44:27 GMT Annexon, Inc. Reports Early Clinical Responses in First U.S. and European Patient Cohort of GBS FORWARD Study with Tanruprubart - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 15:47:18 GMT Annexon Highlights Promising Early FORWARD GBS Study Results - TipRanksTipRanks · Thu, 06 Aug 2026 13:13:24 GMT Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:00:00 GMT Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance - Investing News NetworkInvesting News Network · Thu, 30 Jul 2026 22:06:59 GMT Annexon (Nasdaq: ANNX) obtains up to $200M credit facility from Oxford - Stock TitanStock Titan · Thu, 30 Jul 2026 20:25:37 GMT

Timeline

Fri, 07 Aug 2026 12:41:30 GMTState Street Corporation (ANNX) discloses 9.8M-share, 6% holding in Annexon - Stock Titan

Thu, 06 Aug 2026 19:02:10 GMTAnnexon says tanruprubart shows rapid strength gains in first 10 GBS FORWARD study patients - Bitget

Thu, 06 Aug 2026 17:44:27 GMTAnnexon Announces Positive Clinical Outcomes from GBS FORWARD Study on Tanruprubart - kalkinemedia.com

Thu, 06 Aug 2026 15:47:18 GMTAnnexon, Inc. Reports Early Clinical Responses in First U.S. and European Patient Cohort of GBS FORWARD Study with Tanruprubart - marketscreener.com

Thu, 06 Aug 2026 13:13:24 GMTAnnexon Highlights Promising Early FORWARD GBS Study Results - TipRanks

Thu, 06 Aug 2026 12:00:00 GMTAnnexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Annexon7 live mentions ANNX6 live mentions GBS FORWARD Study6 live mentions Inc6 live mentions Tanruprubart4 live mentions European Patient Cohort4 live mentions Stock Titan2 live mentions GBS FORWARD2 live mentions Annexon Announces Positive2 live mentions Clinical Outcomes2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Annexon Reports First.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.